坤集團(00924.HK):要約人並無就要約股份接獲任何有效接納 要約截止
格隆匯2月24日丨坤集團(00924.HK)公吿,要約已於2023年2月24日下午四時正截止,且要約人並無修訂或延長要約。
於2023年2月24日下午四時正,即綜合文件所載接納要約的最後時限及日期,要約人並無就要約項下的要約股份接獲任何有效接納。
緊隨要約截止後及於本聯合公吿日期,要約人及與其一致行動人士合共於5.5億股股份擁有權益,佔公司已發行股本總數的55.0%。緊隨要約截止後及於本聯合公吿日期,4.5億股股份(相當於本聯合公吿日期公司全部已發行股本45.0%)由公眾人士持有。因此,於本聯合公吿日期,公司繼續符合上市規則第8.08(1)(a)條的最低公眾持股量規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.